Frank S. Menniti
Frank S. Menniti publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology, on topics such as Phosphodiesterase function and regulation, Neuroscience and Neuropharmacology Research and Receptor Mechanisms and Signaling.
- World rank
- #212,706 of 7,710,434 ranked researchers
- Rank in United States
- #78,829 of 1,627,098
- Works
- 141
- Citations
- 13k
- Citations per work
- 95.6
What does Frank S. Menniti research?
Frank S. Menniti's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Neuroscience (18%), Medicine (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences7552.9%
- Biochemistry, Genetics and Molecular Biology5035.3%
- Neuroscience2517.6%
- Everything else3726.4%
- Health Sciences1812.8%
- Medicine1812.8%
- Physical Sciences117.9%
- Chemistry117.9%
- 1Molecular Biology33% of their works
- 2Cellular and Molecular Neuroscience18% of their works
- 3Pharmacology9% of their works
- 4Organic Chemistry8% of their works
- 5Neurology4% of their works
- 6Genetics2% of their works
Research topics
- Phosphodiesterase function and regulation
- Neuroscience and Neuropharmacology Research
- Receptor Mechanisms and Signaling
- Cholinesterase and Neurodegenerative Diseases
- Ion channel regulation and function
- Phenothiazines and Benzothiazines Synthesis and Activities
- Neurotransmitter Receptor Influence on Behavior
- Neuropeptides and Animal Physiology
Which keywords describe Frank S. Menniti's research?
The keywords of their largest research topics: Pharmacology, cAMP Signaling, Cyclic Nucleotide Phosphodiesterases, Neurotransmission, Synaptic Plasticity, Cell Signaling, Crystal Structure and G-Protein-Coupled Receptors.
- Neuropeptides
- Phenothiazines
- Biological Activities
- Ion Channels
- Cholinesterase Inhibitors
- G-Protein-Coupled Receptors
- Cell Signaling
- Neurotransmission
- Cyclic Nucleotide Phosphodiesterases
- Pharmacology
- cAMP Signaling
- Synaptic Plasticity
- Crystal Structure
- Acetylcholinesterase
- Stress
- Voltage-Gated Channels
- Dopamine
- Serotonin
- Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Pharmacology572 topics
- Cyclic Nucleotide Phosphodiesterases481 topic
- cAMP Signaling481 topic
- Neurotransmission451 topic
- Synaptic Plasticity451 topic
- Cell Signaling412 topics
- Crystal Structure301 topic
- G-Protein-Coupled Receptors301 topic
- Acetylcholinesterase271 topic
- Cholinesterase Inhibitors271 topic
- Stress152 topics
- Ion Channels111 topic
- Voltage-Gated Channels111 topic
- Biological Activities81 topic
- Dopamine81 topic
- Phenothiazines81 topic
- Serotonin81 topic
- Neuropeptides71 topic
- Receptors71 topic
Where does Frank S. Menniti work?
Frank S. Menniti's main affiliation in the publication record is Pfizer (United States), United States.
How many publications and citations does Frank S. Menniti have?
OpenAlex counts 141 works and 13,479 citations for Frank S. Menniti, an h-index of 56, ranking #212,706 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Frank S. Menniti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.